Women who experience preeclampsia during pregnancy carry roughly double the risk of stroke and four times the risk of chronic hypertension for decades afterward, according to data synthesized in an AHA/ASA guideline. Multiple large cohort studies tracking participants for 25 to 32 years after their first births have confirmed that these elevated risks persist well beyond the postpartum period, raising the stakes for millions of women who may not realize their pregnancies left a lasting mark on their cardiovascular health.
How Preeclampsia Rewires Long-Term Heart Risk
The connection between preeclampsia and later heart disease is not a loose association. A systematic review and meta-analysis published in Circulation: Cardiovascular Quality and Outcomes found that women with a history of preeclampsia faced significantly elevated risk ratios for coronary heart disease, heart failure, stroke, and cardiovascular death, even after researchers adjusted for confounders including age, BMI, and diabetes. The effect sizes held up across sensitivity analyses, meaning the relationship was not easily explained away by other health factors that tend to cluster alongside high blood pressure.
What makes this finding so consequential is the timeline. An observational cohort tracking women from first birth through 2013 found that hypertensive disorders of pregnancy were tied to later development of chronic hypertension, high cholesterol, and type 2 diabetes, with mean follow-up stretching roughly 25 to 32 years depending on the outcome measured. These are not fleeting postpartum complications. They are intermediate conditions that build over decades and feed directly into the machinery of heart attack and stroke.
A peer-reviewed synopsis of the 2014 AHA/ASA stroke prevention guideline put specific numbers to the danger: a history of preeclampsia is associated with approximately 2-fold stroke risk and 4-fold later hypertension risk. The guideline recommended that clinicians document preeclampsia in medical records so that prevention efforts could be intensified years or even decades after delivery.
Decades of Data from the Nurses’ Health Study II
One of the strongest pieces of evidence comes from the Nurses’ Health Study II, a large prospective cohort that evaluated hypertensive disorders of pregnancy in relation to premature mortality, including death from cardiovascular disease. The Nurses’ Health Study II analysis added a critical endpoint that shorter studies could not capture: death itself. By following participants over an extended horizon, the researchers demonstrated that pregnancy-related hypertension was not simply a predictor of future blood pressure problems but a marker for shortened lifespan driven by cardiovascular causes.
This finding shifts the clinical conversation. A woman diagnosed with preeclampsia at age 28 is not just at higher risk of needing blood pressure medication in her 40s. She faces measurably higher odds of dying from heart disease before she reaches typical life expectancy. The gap between that reality and the standard postpartum follow-up most women receive, which often ends within six weeks of delivery, is striking.
The CDC notes that hypertensive disorders affect a meaningful share of pregnancies and raise immediate postpartum stroke risk. Yet the long-term follow-through remains inconsistent. Many women leave the hospital after a preeclamptic pregnancy without a clear plan for cardiovascular monitoring in the years ahead. The guideline recommendation to document preeclampsia as a lasting risk factor has not translated into universal clinical practice.
Gaps in Screening and the Carotid Thickness Question
One hypothesis that researchers have explored is whether preeclampsia accelerates structural changes in blood vessels at a rate detectable years before traditional risk-factor thresholds are crossed. Specifically, some investigators have examined whether carotid intima-media thickness, a measure of arterial wall buildup visible on ultrasound, progresses faster in women with a history of preeclampsia compared to those without. If confirmed at scale, serial ultrasound screening within the first decade after a preeclamptic pregnancy could identify women on a fast track toward cardiovascular events while intervention is still relatively straightforward.
The available evidence from the sources reviewed here does not include specific carotid intima-media thickness measurements or confirm a validated screening protocol based on that metric. The cohort studies focused on clinical endpoints like hypertension diagnosis, cholesterol levels, diabetes onset, and mortality rather than subclinical imaging markers. That leaves a gap between the strong epidemiological signal and a practical early-detection tool that clinicians could deploy in routine postpartum care.
Race and ethnicity-stratified risk estimates are also absent from the primary sources examined. Given that Black women in the United States experience higher rates of both preeclampsia and cardiovascular disease, the lack of granular data on how these risks compound across demographic groups is a significant blind spot. Broad population-level averages can mask disparities that matter most for the women at greatest risk.
What Women and Clinicians Can Do Now
For women who experienced preeclampsia or other hypertensive disorders during any pregnancy, the most direct step is to ensure that diagnosis is recorded in their ongoing medical records and raised with their primary care provider, not just their obstetrician. The AHA/ASA guideline specifically called for this documentation so that clinicians can incorporate pregnancy history into long-term cardiovascular risk assessment, much as they already do with smoking status or diabetes.
Women can also ask for periodic checks of blood pressure, fasting lipids, and blood glucose starting in early midlife, or earlier if they already have borderline readings. The long follow-up from the hypertensive pregnancy cohort suggests that chronic hypertension, dyslipidemia, and type 2 diabetes often emerge years before a heart attack or stroke, creating a window in which lifestyle changes and medications can substantially lower risk.
Clinicians, for their part, can normalize questions about pregnancy complications during routine visits with adult women, regardless of how long it has been since childbirth. A brief intake question such as “Did you ever have high blood pressure or preeclampsia during pregnancy?” can surface patients who merit closer monitoring. When the answer is yes, it should prompt a lower threshold for initiating preventive strategies like blood pressure control, statin therapy when indicated, and counseling on diet, exercise, and smoking cessation.
Health systems and electronic medical record vendors can help by building structured fields for hypertensive disorders of pregnancy into problem lists and risk calculators. If preeclampsia status were as visible in charts as a prior myocardial infarction, it would be harder for busy clinicians to overlook its relevance decades later. Quality-improvement initiatives could track how often this history is documented and whether those patients receive guideline-concordant cardiovascular screening.
Finally, researchers can address the remaining blind spots by designing studies that oversample populations at highest risk, including Black, Indigenous, and other women of color, and by integrating subclinical imaging markers such as carotid intima-media thickness into long-term follow-up. Linking these imaging findings to hard outcomes like stroke and cardiovascular death would clarify whether earlier, more intensive screening meaningfully changes trajectories after a preeclamptic pregnancy.
The evidence already on hand paints a consistent picture: preeclampsia is not just a complication of pregnancy but an early warning signal of future cardiovascular disease. Recognizing that signal, recording it, and acting on it across the lifespan could transform a short-lived obstetric diagnosis into a powerful tool for prevention.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
